Tumor treating fields combined with a poly (adenosine diphosphate-ribose) polymerase inhibitor during radiotherapy for rapidly progressing IDH-wildtype diffuse astrocytoma: a case report
A 57-year-old woman was diagnosed with IDH-wildtype (IDHwt) astrocytoma (World Health Organization grade II) with the molecular characteristics of glioblastoma. She underwent concurrent radiotherapy and chemotherapy according to the Stupp protocol in combination with a multi-target antiangiogenic dr...
Main Authors: | Zheng Wang, Yi Ren, Fangfang Du, Yafang Sun, Wei Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-08-01
|
Series: | Journal of International Medical Research |
Online Access: | https://doi.org/10.1177/03000605211036847 |
Similar Items
-
The role of surgery in IDH wildtype diffuse astrocytomas
by: Harald Krenzlin, et al.
Published: (2023-01-01) -
Expression of poly(Adenosine Diphosphate-Ribose) polymerase protein in breast cancer
by: Akanksha, et al.
Published: (2022-01-01) -
Strategies for the Use of Poly(adenosine diphosphate ribose) Polymerase (PARP) Inhibitors in Cancer Therapy
by: Thomas Helleday, et al.
Published: (2012-12-01) -
Prognostic and clinicopathological value of poly (adenosine diphosphate-ribose) polymerase expression in breast cancer: A meta-analysis.
by: Weiqiang Qiao, et al.
Published: (2017-01-01) -
Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor radiotherapy sensitization
by: Yi Zhang, et al.
Published: (2023-12-01)